一例系统性淀粉样变性患者心肌对68Ga-戊抑素(68Ga-Pentixafor)的摄取
55岁男性因胸闷、下肢水肿1年就诊,实验室及影像检查提示心脏淀粉样变性。18F-FDG与68Ga-戊抑素PET/CT均显示左心室心肌摄取增高,骨髓弥漫轻度摄取68Ga-戊抑素但无骨质破坏,99mTc-MDP骨显像见心、肠、肾及软组织骨外摄取,腹部皮下脂肪活检证实淀粉样沉积,最终诊断原发性系统性淀粉样变性。本例提示心脏淀粉样变性可能表现为心肌68Ga-戊抑素摄取增高。
要点
- 心脏淀粉样变性患者心肌可表现为68Ga-戊抑素摄取增高。
- 99mTc-MDP骨显像可检出心、肠、肾及软组织骨外摄取。
- 骨髓弥漫轻度68Ga-戊抑素摄取不伴骨质破坏可见于系统性淀粉样变性。
核心结论
- 本例提示心脏淀粉样变性可能表现为心肌68Ga-戊抑素摄取增高。
研究设计与样本
- 病例报告,报道一例55岁男性系统性淀粉样变性患者。
主要发现
- 18F-FDG PET/CT显示左心室心肌摄取增高。
- 68Ga-戊抑素PET/CT显示左心室心肌摄取增高,骨髓弥漫轻度摄取68Ga-戊抑素且无骨质破坏。
- 99mTc-MDP骨显像检出心、肠、肾及软组织骨外摄取。
- 腹部皮下脂肪活检证实淀粉样沉积,最终诊断为原发性系统性淀粉样变性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 55-year-old man presented with chest tightness and lower-limb edema for 1 year. Laboratory and imaging examinations suggested cardiac amyloidosis. Both 18F-FDG and 68Ga-pentixafor PET/CT showed increased uptake in the myocardium of the left ventricle, whereas the bone marrow had diffusely mild uptake of 68Ga-pentixafor without bone destruction. 99mTc-MDP bone scintigraphy also detected extraosseous uptake in the heart, gut, kidneys, and soft tissue. The biopsy of the abdominal subcutaneous fat confirmed amyloid deposits, and the patient was finally diagnosed with primary systemic amyloidosis. This case demonstrated that cardiac amyloidosis might show increased 68Ga-pentixafor uptake in myocardium.
引用
- Pan Q, Luo Y, Cao X, et al. Myocardial Uptake of 68Ga-Pentixafor in a Patient With Systemic Amyloidosis. Clin Nucl Med. 2022. PMID: 36342801. doi:10.1097/RLU.0000000000004406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。